Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 92 for “"Prostate--Cancer--Treatment"”.
-
Multifactorial Targeting of the Prostate Cancer Treatment Landscape
In 2023, prostate cancer had the highest rate of incidence and second highest rate of mortality in men in the United States. Currently approved therapies, such as hormone therapies and chemotherapies, serve to slow down cancer progression but are unable to cure it permanently. Therefore, it is …
-
Developments in prostate cancer treatment. Improving complication rates.
Contains fulltext : 92726.pdf (Publisher’s version ) (Open Access)
-
From Discovery to Validation: Novel Human Antibodies for Prostate Cancer Treatment
Prostate cancer is the second most commonly diagnosed malignancy in men worldwide, with over 35,000 deaths reported in the United States in 2024. While the 5-year overall survival approaches 100% when the disease remains localized, prognosis worsens when the cancer disseminates, with survival rates …
-
Identification of critical hypoxia-induced factors in prostate cancer treatment resistance
Prostate cancer (PCa) is the second leading cause of cancer-related death in men worldwide. Despite advances in androgen deprivation therapy (ADT) and radiation therapy, many tumours progress to castration-resistant prostate cancer (CRPC).m Tumour hypoxia further promotes therapeutic resistance and …
-
Repositioning aspirin and metformin to improve prostate cancer treatment and outcome
Prostate cancer is the second most common cancer in males worldwide and the fifth most common cause of cancer death among men. Identifying drugs which prevent prostate cancer initiation and development is a major goal in the field of cancer research, with a large focus on repositioning established …
-
Evaluating the quality of online health information about prostate cancer treatment
BACKGROUND: Prostate cancer is one of the most common cancers amongst men, yet it is a surprisingly complex disease. There are currently multiple options for treatment, depending on the stage of the cancer, with new methods currently under investigation. Patients can easily get confused about these …
-
Prostate cancer treatment optimization - Implementing liquid biopsies and dose selection approaches
Contains fulltext : 284399.pdf (Publisher’s version ) (Open Access)
-
Impact of prostate cancer treatment on pelvic nerve injury and erectile function
Following prostate cancer treatment, many men will experience urogenital side effects including erectile dysfunction (ED), a condition significantly affecting survivor quality of life. The cause of ED after treatment is frequently unknown, but injury to the inferior hypogastric plexus, a collection …
-
Tumor-specific targeting using oncolytic herpes simplex virus type 1 for prostate cancer treatment
Prostate cancer is the most common non-skin cancer, and the second leading cause of cancer-death in men. Current treatments, including androgen withdrawal therapy, are not curative for advanced metastatic disease and new treatment strategies are urgently required. In this regard, oncolytic …
-
The role of tomato and lycopene consumption on prostate carcinogenesis and prostate cancer treatment
Prostate cancer (PCa) is most commonly diagnosed cancer among men in the United States. Following PCa diagnosis, men often seek information about foods and supplements that may improve their response to therapies, quality of life and survival. Tomatoes and their primary bioactive (lycopene) are one …
-
Using an ultrasound-derived model to assist in dosimetry for prostate cancer treatment through brachytherapy
Prostate cancer is the most common form of cancer affecting men in Canada. Patients with localized, early stage disease are often treated using prostate brachytherapy, a technique that involves surgically implanting small radioactive capsules or “seeds” in the prostate. Implantation is performed …
-
Discovery and Mechanistic Study of Novel PBD-Targeted Inhibitors of PLK1 for Prostate Cancer Treatment
… their potent antiproliferative activity in prostate tumors and other cell lines. Furthermore, the abbapolins show PLK1-specific binding and inhibitory activity as measured by a cellular thermal denaturation assay and their ability to block phosphorylation of TCTP, a key marker of PLK1 …
-
Design of a 2D MRI compatible robot for performing prostate cancer treatment using therapeutic ultrasound
Therapeutic ultrasound is a promising treatment method for many common cancers, including prostate cancer. Magnetic resonance image (MRI) guidance of therapeutic ultrasound permits targeting and monitoring of therapy. In this thesis a prototype MRI compatible positioning device for the treatment of …
-
INFLUENCE OF PRIMARY CARE PROVIDER INVOLVEMENT ON PROSTATE CANCER TREATMENT PATTERNS AMONG MEN WITH LOCALIZED DISEASE
… calls for greater integration of primary and cancer care, the role of primary care providers (PCPs) across the cancer care continuum remains poorly defined. With longitudinal relationships with their patients, PCPs may ideally help patients make cancer treatment decisions that are better in …
-
Mental Wellbeing in Prostate Cancer Treatment and Survivorship: Outcome Definition, Prognostic Factors, and Prognostic Model Development
A prostate cancer diagnosis and its subsequent management can produce numerous challenges to patients. With already significant and further improving survival rates there is a growing realisation that living longer does not always equate to living well. This means that issues pertaining to quality …
-
Characterising the mechanism of DCUN1D1 activity in prostate cancer and identifying DCUN1D1 inhibitors for prostate cancer treatment
… in our lab demonstrated the role of DCUN1D1 in prostate cancer in vitro and in vivo. We also identified potential inhibitors of DCUN1D1 which inhibited the proliferation of prostate cancer cells in a DCUN1D1-specific manner. This study seeks to determine the mechanism of action of DCUN1D1 in …
-
Pre-clinical evaluation of theranostic [177Lu]Lu-PSMA617 prostate cancer treatment in combination with adjuvant agonistic OX40-targeting
Prostate cancer represents a significant disease burden worldwide. While recent advancements in diagnostics and therapy have increased both overall and progress-free survival in PCa, relapses are common, and progression to the metastatic phenotype continues to block therapeutic efforts, often …
-
Prostate cancer treatment as an embodied rite of passage: impotence and incontinence as challenges to status reversal and reintegration
… can interpret and understand men’s experience of prostate cancer diagnosis and treatment, and their struggle to regain power and control in the context of diagnosis, and also the side effects to treatment. The strategies men adopt in seeking out personalised medical programmes of treatment with …
Page 1 of 5